Medtronic (NYSE:MDT) has received FDA 510(k) clearance for its Nellcor pulse oximetry system with the Nell-EQ intelligent ...
January 22, 2026 /3BL/ – Medtronic, a global leader in healthcare technology, announced verification study results for its investigational Nellcor™ pulse oximetry with Nell-EQ™ intelligent processor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results